{"id":"W2107365189","doi":"10.1158/1078-0432.ccr-04-0097","title":"A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Carboplatin; Medicine; Topotecan; Fludarabine; Internal medicine; Leukemia; Regimen; Gastroenterology; Acute leukemia; Platelet transfusion; Oncology; Surgery; Chemotherapy; Cyclophosphamide; Platelet; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007689851,0.0009992912,0.001503889,0.0002124143,0.0002611896,0.000546472,0.0005323213,0.0006493253,0.001006418],"category_scores_gemma":[0.001005196,0.0003301515,0.0006107501,0.0002578697,0.0006905422,0.0004564273,0.0002086872,0.001483235,0.0002672679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006842248,"about_ca_system_score_gemma":0.0008960582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006375922,"about_ca_topic_score_gemma":0.001312038,"domain_scores_codex":[0.9996191,0.0001754844,0.00002234641,0.00006043713,0.00004537034,0.00007708605],"domain_scores_gemma":[0.9994837,0.0001155996,0.0001083528,0.00003724262,0.00002448289,0.0002307447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5423509,0.05316212,0.09066079,0.0006531691,0.00187958,0.001015217,0.0005470433,0.007663523,0.09260718,0.0003434169,0.002993325,0.2061237],"study_design_scores_gemma":[0.271905,0.6113847,0.08963177,0.00003896343,0.0008316754,0.001962915,0.0001075452,0.00426991,0.01461917,0.0002092029,0.004988311,0.00005082608],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998059,0.0008600654,0.0002437901,0.000105558,0.00002102529,0.0002430297,0.0001023898,0.00002297353,0.0003420657],"genre_scores_gemma":[0.9973138,0.0004067163,0.0007861367,0.0002174651,0.0000760124,0.0003636508,0.0005061061,0.000006515711,0.0003236681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001503889,"threshold_uncertainty_score":0.004964471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06352704510688084,"score_gpt":0.4685404394304402,"score_spread":0.4050133943235594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}